2015-07-16 15:22
Kangmei pharmaceutical Ma Xingtian: ＂small package＂ change Chinese giant achievement
|
12 years, the United States and the United States to achieve a big leap in the size of the capital, the total share capital and stock market value increased by 32 times and 264 times, the current total assets of more than 4500000000 yuan. From the earnings report, the Chinese herbal medicine production enterprises four years ago to enter the Leap Period: 2005 to 2008 three years, its annual sales from 585000000 yuan to 1727000000, the total assets also turned 6 times.
[] sword
Kang beauty leveraging the explosive growth of the "golden key" seems simple -- "small package of Chinese herbal pieces". Qiu Xiwei, deputy general manager of the United States, said: "do not look at this is a small reform, it is changing China since ancient times' hand grasp scale volume 'of traditional Chinese medicine, which embodies the health beauty how much effort."
Who decided to join the western medicine Chinese medicine standardized
Review of "Chinese medicine Giant" Kangmei growth experience, at least two magnificent turn strategy.
Created a joint venture private nature of the "Guangdong Province Kang beauty Pharmaceutical Co., Ltd." in 1995, Ma Xingtian wives Xu Dongjin, June 9, 1997 officially banner as "Guangdong, Hong Mei Pharmaceutical Co., Ltd., in on the road of modern enterprise has taken a crucial step. March 2001, the company's shares listed in Shanghai securities, securities code: 600518.
SIG Combibloc is the first medicine started with Hong Mei Luo Xin Ping, Kang Meipei Ning, Kang Meili Lok, Hong Mei Bendict and other national drug. Hong Mei looked increasingly prosperous, Ma Xingtian realized that "if it continues to western road, in front of too many mountains to cross, to go the path of traditional Chinese medicine and more core competitiveness."
After a full investigation and boldly predicted that Hong Mei targeting Chinese medicine industry, the scale of the road. Ma Xingtian believes that small, scattered, chaotic characteristics of the industry and the traditional production and processing shop in front Square model has been a serious impediment to the development of the industry, generally poor quality of Chinese Herbal Medicine may lead to the decline of the entire pharmaceutical industry.
In 2002, the US pharmaceutical in the capital strength is not strong situation, we decided to spend $ 100 million investment to build the largest and highest starting point, Chinese Herbal Medicine to achieve large-scale production of modern Chinese Herbal Medicine industrialization demonstration base.
He won the first battle. Hong Mei Chinese Herbal Medicine Base after a construction period of just eight months to achieve a normal production and operations. October 2003, Health America Pharmaceutical become one of the first pilot by the National Chinese Herbal Medicine GMP certification business model. By 2004, SIG Combibloc has annual sales of over 500 million.
"Small package" innovation leveraging industry change
May 1, 2005, Kang beauty is a memorable day. From this day, China's largest Chinese medical institutions --- Guangdong Provincial Hospital of Chinese Herbal Medicine to enable all small package, but also in all the country's first hospital Pieces small package, is the US pharmaceutical supply companies. TCM leading role model units for the US pharmaceutical industry to establish a leading position laid a solid foundation.
Since ancient times, Chinese medicine were sent to take "clutch weighing" approach. Health America Pharmaceutical then issued a challenge to the traditional folk medicine, the implementation of Chinese Herbal Medicine "small package." All kinds of Chinese herbal medicines are in bags according to 3g, 5g, 10g and 15g and other goods regulations. As a result: Chinese medicine prescription, measurement units directly from the "g" to "package"; when you fill a prescription is no longer "Everyone waist of a steelyard" and avoiding secondary pollution caused by the clutch.
Another significance of the "small package" to bring quality and dose stability. Ma Xingtian said the Chinese pay attention to "syndrome differentiation", for different people to take different treatment methods, which requires medication "dosage to be accurate."
However, due to the long-standing lack of industry standards, with a Chinese herbal medicine, different origin, different manufacturers, may lead to medicines in the same amount of active ingredients far. And a foundation of traditional Chinese medicine bags behind the GMP certification standards and fingerprint authentication, both of which can guarantee the stability of the active ingredients of Chinese herbal medicines. And Kang Meixi hope to do is to "lead the industry to establish a uniform standard."
According to reports, Kang America Pharmaceutical Chinese Herbal Medicine has been involved in national industry standard drafting and formulation, including production, testing, distribution, and other aspects of clinical applications. "It is now up part of the standard, and it should soon be launched."
Hong Mei's "little innovation", is set off a vigorous change in the industry. The moment, at the national level is working to promote Chinese Herbal Medicine "small package" campaign. This year, the various types of three Chinese Medicine Hospital and part of the larger two Chinese medicine hospital will impose "small package."
Two or three years, the US pharmaceutical industry is also due to break through the bottleneck and ushered in a company's own "explosive growth." US pharmaceutical annual sales revenue reached 1.727 billion, three times to promote the "small package" before. SIG Combibloc has been far in the forefront of development of the industry. At present, the domestic largest after the US pharmaceutical market ranks second Pieces of Chinese medicine production enterprises, the annual income level of about 10 million to 100 million yuan in a few between.
[Mountain] Health America Pharmaceutical chairman Ma Xingtian: accelerate the realization of the layout of three-dimensional expansion
Reporter: You mentioned Hong Mei Chinese Herbal Medicine are participating in the national industry standard drafting and formulation, which is business development mean?
Ma Xingtian: This is a product from the production to the production standard of sublimation. First-class enterprise standards, second-rate companies to do technology, third-rate companies make products. In the modern enterprise competition, who can develop industry and national standards of a particular area or product, whoever occupied the commanding heights.
Pieces of Chinese medicine industry has just entered the time, SIG Combibloc also experienced a lack of standard products brings confusion and pain, often confused in different customer requirements. How to break the bottleneck of the industry? Conduct standardized production and implementation of standardized management is the only way.
To this end, the US pharmaceutical invested a lot of money and manpower to do the standard of this one, including this year shared with other units of the national "standard Chinese Herbal Medicine Research platform", "Chinese standard of technical system specifications" two topics. This is for the protection and development in the pharmaceutical industry of great significance and far-reaching.
Reporter: This year Combibloc frequent moves in the capital, has entered a period of rapid expansion is the strategy?
Ma Xingtian: Health America Pharmaceutical business advantages to the advantage of funds varieties of Chinese herbal medicines, this business model has been effectively verified, the business has expanded rapidly, while Combibloc is also stepping up the implementation of the peripheral expansion strategy. This year there are several large actions, the establishment of subsidiaries are in Chengdu, Beijing, Jilin and other places.
At present, Hong Mei Chinese Herbal Medicine to industry as the core, through upstream and downstream, "Chinese herbal medicine - Chinese Herbal Medicine - Hospital - chain pharmacies," the industry chain integration model has been taking shape. The next few years, we will further accelerate the pace of expansion of Kang Meili body to achieve national distribution.
Reporter: Can you describe what the United States and the future development blueprint for health?
Ma Xingtian: the stage of laying the foundation is still the hope that Chinese Herbal Medicine to expand production fivefold in two or three years, and the Chinese logistics port built into the country's largest logistics base best medicine. Our vision is to achieve localization "Rise Combibloc" dream, to establish Chinese medicine industry benchmark, demonstration enterprises.
We have the responsibility to Chinese medicine treasure this legacy of our ancestors to flourish, it requires constant innovation. I believe Combibloc have the ability to innovate. Hong Mei everyone is like a wolf, wolf spirit, unity and hard work, we dare daring. ▲
(Original title: Health America Pharmaceutical Ma Xingtian: "small package" change medicine giant achievements)
Editor: Wan Wan
|
[CNDSN7 on the 16th of news (China Food Machinery Network) in the eastern port city Puning, people talk about Chinese medicine often flashed two signs: one is here has since the Ming and Qing Dynasties era on the development of Chinese herbal medicine market; the second is a rapid growth of Chinese herbal medicine city company -- Kangmei pharmaceutical.